Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2020 TO 2029]"
topic_facet:"EC 2.7.10.1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=topic_facet%3A%22EC+2.7.10.1%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (315)
1
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
enthalten in:
The New England journal of medicine
| 2024
von
Wu, Y.
|
Dziadziuszko, R.
|
Ahn, J.
| +120
Wird geladen...
2
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2024
von
Park, S.
|
Kim, T.
|
Han, J.
| +21
Wird geladen...
3
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors : Final Results of CheckMate 722
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2024
von
Mok, T.
|
Nakagawa, K.
|
Park, K.
| +20
Wird geladen...
4
Patient-Reported Outcomes in OlympiA : A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2024
von
Ganz, P.
|
Bandos, H.
|
Španić, T.
| +43
Wird geladen...
5
KESTREL and KITE Phase 3 Studies : 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema
enthalten in:
American journal of ophthalmology
| 2024
von
Wykoff, C.
|
Garweg, J.
|
Regillo, C.
| +12
Wird geladen...
6
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR) : 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
enthalten in:
Lancet (London, England)
| 2024
von
Lanzetta, P.
|
Korobelnik, J.
|
Heier, J.
| +22
Wird geladen...
7
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON) : 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
enthalten in:
Lancet (London, England)
| 2024
von
Brown, D.
|
Boyer, D.
|
Do, D.
| +124
Wird geladen...
8
Ribociclib plus Endocrine Therapy in Early Breast Cancer
enthalten in:
The New England journal of medicine
| 2024
von
Slamon, D.
|
Lipatov, O.
|
Nowecki, Z.
| +28
Wird geladen...
9
Abemaciclib as adjuvant treatment for high-risk early breast cancer
enthalten in:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
| 2024
von
Ganfornina Andrades, A.
|
Fénix Caballero, S.
|
Salguero Olid, A.
| +1
Wird geladen...
10
Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer : final analysis of the randomized phase III PEONY trial
enthalten in:
Nature communications
| 2024
von
Huang, L.
|
Pang, D.
|
Yang, H.
| +21
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2020-2029
Filter aufheben
Thema: EC 2.7.10.1
Medienart
315
Aufsätze
315
E-Artikel
315
E-Ressourcen
Zeitschriftentitel
29
Journal of clinical oncology : official journal...
17
The New England journal of medicine
16
Breast cancer research and treatment
16
The Lancet. Oncology
13
Future oncology (London, England)
11
Annals of oncology : official journal of the Eu...
9
JAMA oncology
8
Cancer science
8
Clinical cancer research : an official journal ...
8
Lancet (London, England)
7
Journal of thoracic oncology : official publica...
7
The oncologist
6
Breast cancer research : BCR
6
European journal of cancer (Oxford, England : 1...
5
Breast (Edinburgh, Scotland)
5
Cancer
5
Clinical lung cancer
5
Lung cancer (Amsterdam, Netherlands)
5
Targeted oncology
5
The Lancet. Respiratory medicine
Alle anzeigen ...
weniger ...
Thema
315
Clinical Trial, Phase III
EC 2.7.10.1
313
Journal Article
266
Randomized Controlled Trial
174
Research Support, Non-U.S. Gov't
165
Receptor, ErbB-2
139
Multicenter Study
76
ERBB2 protein, human
67
P188ANX8CK
67
Trastuzumab
65
ErbB Receptors
59
Protein Kinase Inhibitors
53
Antibodies, Monoclonal, Humanized
51
EGFR protein, human
50
Receptors, Estrogen
45
Comparative Study
40
Receptors, Vascular Endothelial Growth Factor
38
Recombinant Fusion Proteins
32
Angiogenesis Inhibitors
31
Aminopyridines
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2020-
17
2024
55
2023
69
2022
92
2021
82
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
314
Englisch
1
Chinesisch
Haven't found what you're looking for?
Wird geladen...